Table 3. Mean daily undiscounted per-patient costs of AAP: Raw reported doses and imputed doses.
Number of patients | Daily cost of reported dose | Daily cost of imputed dose | Treatment duration (days) | ||||||
---|---|---|---|---|---|---|---|---|---|
n events | mean (£) | SD (£) | n events | mean (£) | SD (£) | mean | SD | ||
Abiraterone | |||||||||
AAP+SOC arm | 951 | 1154 | 94.69 | 10.37 | 1184 | 94.77 | 10.24 | 590.2 | 438.7 |
SOC-only arm | 121 | 0 | - | - | 127 | 97.68 | 0.00 | 256.9 | 235.0 |
Prednisolone | |||||||||
AAP+SOC arm | 951 | 3 | 0.07 | 0.04 | 1186 | 0.02 | 0.00 | 589.0 | 439.2 |
SOC-only arm | 122 | 1 | 0.09 | - | 128 | 0.02 | 0.01 | 255.2 | 234.8 |
Treatment duration was counted to censor date or earlier. There are more ‘events’ than patients because some patients stopped then re-started. SD = standard deviation; AAP = abiraterone acetate plus prednisone/prednisolone; SOC = standard of care.